molecular diagnostics

  • Placeholder

    Jak 2 Exon 12-15 Mutation Analysis | Accurate Genetic Testing & Results

    2.720,00 د.إ

    The Jak 2 Exon 12-15 Mutation Analysis is a specialized genetic test designed to detect mutations in exons 12-15 of the JAK2 gene, which are associated with myeloproliferative neoplasms (MPNs) such as polycythemia vera (PV) and other hematologic disorders. This test offers high sensitivity and specificity, enabling early and accurate diagnosis, which is crucial for targeted treatment decisions and disease monitoring. Unlike standard JAK2 V617F mutation tests, this analysis identifies rare but clinically significant mutations, providing comprehensive genetic profiling for patients with suspected MPNs. Its advanced molecular technology ensures reliable results, supporting personalized therapeutic strategies and improving patient outcomes.

  • Placeholder

    Liquid HALLMARK (Liquid Biopsy)

    13.000,00 د.إ

    Liquid HALLMARK is a comprehensive liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from a simple blood draw to detect and monitor cancer.

    Sample Type : Serum

    Methodology : Ultra-deep sequencing using Lucence’s proprietary AmpliMARK™ technology

    TAT : 8-10 Days

  • Neisseria gonorrhoeae

    Neisseria gonorrhoeae (P.C.R) | Fast, Accurate & Non-Invasive STI Testing in Dubai

    450,00 د.إ

    Suspect gonorrhea? The Neisseria gonorrhoeae PCR test detects STI from urine or swab. Results in 1 day. Fast, accurate & discreet in Dubai. Book online now.

    Sample Type : Dry Swab / Urine
    Methodology : Real-time PCR
    TAT : 1 Day

  • Placeholder

    Oncomine Acute Myeloid Leukemia (AML) Panel – Targeted NGS Solution for AML Research

    5.500,00 د.إ

    The Oncomine Acute Myeloid Leukaemia (AML) Panel is a targeted next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of AML. It enables simultaneous detection of key mutations, gene fusions, and copy number variations across clinically relevant genes associated with AML.

  • Placeholder

    Oncomine Myeloproliferative Neoplasm (MPN) Panel – Accurate NGS Testing for MPN Mutations

    5.500,00 د.إ

    The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a targeted next-generation sequencing (NGS) assay designed for the comprehensive detection of key driver mutations in myeloproliferative neoplasms. It enables the simultaneous analysis of JAK2, CALR, and MPL genes, which are critical for MPN diagnosis and classification. The panel offers high sensitivity, detecting low-frequency variants with as little as 10 ng of input RNA or DNA, making it ideal for limited or degraded samples.

  • Oncotype DX Breast Cancer Test

    Oncotype DX Breast Cancer Test – Personalized Risk Assessment & Treatment Guidance

    35.000,00 د.إ

    The Oncotype DX Breast Cancer (ML) Test is a genomic assay that analyzes the activity of 21 genes in a breast cancer tumor to predict the risk of recurrence and the potential benefit of chemotherapy. Designed for early-stage, hormone receptor-positive, HER2-negative breast cancer patients, it provides a Recurrence Score® result that helps guide personalized treatment decisions. Key benefits include reducing unnecessary chemotherapy, improving patient outcomes, and offering evidence-based insights backed by extensive clinical validation.

  • STD 8 Panel (Real Time PCR)-Chlamydia Trachomatis, Mycoplasma Genitalium,Trichomonas Vaginalis,Ureaplasma Parvum,Ureaplasma Urealyticum,Mycoplasma Hominis, Neisseria Gonorrhoeae, Gardnerella Vaginalis

    STD 8 Panel (Real Time PCR)-Chlamydia Trachomatis, Mycoplasma Genitalium,Trichomonas Vaginalis,Ureaplasma Parvum,Ureaplasma Urealyticum,Mycoplasma Hominis, Neisseria Gonorrhoeae, Gardnerella Vaginalis

    575,00 د.إ

    The STD 8 Panel (Real Time PCR) is a comprehensive diagnostic test that detects eight common sexually transmitted pathogens: Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Neisseria gonorrhoeae, and Gardnerella vaginalis. Utilizing advanced real-time PCR technology, it offers high sensitivity and specificity for accurate, early detection.

    Sample Type : Dry Swab / Urine

    Methodology : PCR

    TAT : 1 Day

  • Placeholder

    Whole Exome Sequencing

    5.375,00 د.إ

    Whole Exome Sequencing (WES) is a powerful genetic testing method that sequences all protein-coding regions (exons) of the genome, covering approximately 1-2% of the DNA where most disease-causing mutations occur. It offers a cost-effective alternative to whole genome sequencing while providing high-depth coverage for accurate variant detection. WES enables the identification of genetic mutations linked to inherited disorders, cancer, and rare diseases, making it a valuable tool for clinical diagnostics, personalized medicine, and research.

WhatsApp Call